RPS responds to Advisory Council on the Misuse of Drugs consultation regarding the legal constraints on researching controlled drugs

Response calls for barriers that restrict legitimate research with controlled drugs (other than synthetic cannabinoids) to be removed, and highlights that allowing flexibility around licensing, storage, formulation and clinical supply would facilitate more fundamental UK research

Royal Pharmaceutical Society